您的位置: 首页 > 2018年3月 第49卷 第2期 > 文字全文
2023年7月 第38卷 第7期11
目录

关节镜下清理术联合中药熏洗治疗痛风性膝关节炎的临床疗效观察

Observation on gouty arthritis of knee joint treated by arthroscopic debridement combined with Chinese medicine fumes

来源期刊: 广州医药 | 104-108 发布时间:2021-12-01 收稿时间:2025/11/13 17:24:13 阅读量:7
作者:
关键词:
关节镜痛风性膝关节炎中药熏蒸
Gouty arthritisArthroscopicChinese medicine fumes
DOI:
10.3969/j.issn.1000-8535.2018.02.027
收稿时间:
2017-10-13 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 观察关节镜下清理术联合中药熏洗治疗痛风性膝关节炎的临床疗效。方法 收集2013年7月—2016年7月期间收治于我院骨科的痛风性膝关节炎患者,根据纳入及排除标准,获得44例患者,共44个膝关节。根据术后是否采用中药熏洗治疗,将其分为治疗组25例及对照组19例。观察内容:术后1周及术后3月的WBC、BUA、ESR、CRP、膝关节疼痛VAS、Lysholm关节功能评分;2组患者术后6月、12月随访时的膝关节疼痛VAS、Lysholm关节功能评分。结果 ①2组患者术前与术后1周的膝关节疼痛VAS、 Lysholm关节功能评分组内比较差异有统计学意义(P<0.05),术后1周的膝关节疼痛VAS、 Lysholm关节功能评分组间比较差异无统计学意义(P>0.05)。②2组患者术前与术后3月随访的WBC、BUA、ESR、CRP组内比较差异有统计学意义(P<0.05),术后3月随访的WBC、BUA、ESR、CRP组间比较差异无统计学意义(P>0.05)。③2组患者术后3月、6月、12月随访的膝关节疼痛VAS、Lysholm关节功能评分组间比较,差异有统计学意义(P<0.05)。结论 关节镜下清理术结合中药治疗痛风性膝关节炎能有效减轻患者膝关节疼痛,值得临床使用。
Objective Retrospective evaluation of the curative effect of the arthroscopic debridement combined with Chinese medicine fumes in the treatment of the gouty arthritis of knee joint.Methods We analyzed 44 patients (from July 2013 to July 2016 in the orthopaedic department of the Sichuan Second T.C.M.Hospital)with gouty arthritis of knee joint. The all 44 patients were divided into treatment group and control group according to postoperative management that whether or not to apply Chinese medicine fumes.The treatment group,25 patients, were all treated by arthroscopic debridement combined with Chinese medicine fumes,and the control group,19 patients, were all treated by arthroscopic debridement only.The observation targets were as follows: VAS、Lysholm、WBC、BUA、ESR、CRP of postoperative after 1 week, 3 months,and VAS、Lysholm. postoperative VAS、Lysholm after 6months、12months.Results Compared the preoperative contents with postoperative contents after1 week,there was statistically significant difference in VAS、Lysholm of both groups(P<0.05).There was no statistically significant difference in VAS、Lysholm in postoperative 1 week between two groups (P>0.05). Compared the preoperative contents with postoperative contents after 3 month,there was statistically significant difference in WBC、BUA、ESR、CRP of both groups(P<0.05).There was no statistically significant difference in WBC、BUA、ESR、CRP of postoperative 3 months between two groups(P>0.05). There was statistically significant difference in VAS、Lysholm of postoperative 3 months and 6 months between two groups(P<0.05).Conclusion Arthroscopic debridement combined with Chinese medicine fumes may improve the quality of life in the treatment of gouty arthritis of knee joint,and it is worthy of wide clinical application.
1、 李浩,陈建锋.关节镜微创术结合中药内服治疗膝关节急性痛风性关节炎[J].中国中医急症,2015,24(10):1850-1852. 李浩,陈建锋.关节镜微创术结合中药内服治疗膝关节急性痛风性关节炎[J].中国中医急症,2015,24(10):1850-1852.
2、 滕毅,杨海玲.冰片在药代动力学方面的研究进展[J].中国临床药理学与治疗学,2015,20(4):469-473. 滕毅,杨海玲.冰片在药代动力学方面的研究进展[J].中国临床药理学与治疗学,2015,20(4):469-473.
3、 JIANG Z K, XIAO L I,LUO B. Anti-inflammatory and analgesic effects of essential oil from chrysanthemi indici flos[J].Chin J Exp Tradit Med Form,2015,21(16):124-127. JIANG Z K, XIAO L I,LUO B. Anti-inflammatory and analgesic effects of essential oil from chrysanthemi indici flos[J].Chin J Exp Tradit Med Form,2015,21(16):124-127.
4、 朱艺欣,李宝莉,马宏胜,等.白芷的有效成分提取、药理作用及临床应用研究进展[J].中国医药导报,2014,11(31):159-162. 朱艺欣,李宝莉,马宏胜,等.白芷的有效成分提取、药理作用及临床应用研究进展[J].中国医药导报,2014,11(31):159-162.
5、 李春娜,刘洋洋,李朋收.东北天南星化学成分及药理作用[J].吉林中医药,2015,35(3): 293-296. 李春娜,刘洋洋,李朋收.东北天南星化学成分及药理作用[J].吉林中医药,2015,35(3): 293-296.
6、 侯小涛,戴航,周江煜.黄柏的药理研究进展[J].时珍国医国药,2007,18(2):498-500. 侯小涛,戴航,周江煜.黄柏的药理研究进展[J].时珍国医国药,2007,18(2):498-500.
7、 邓爱萍,李颖,吴志涛,等.苍术化学成分和药理的研究进展[J].中国中医药杂志,2016,41(21):3904-3911. 邓爱萍,李颖,吴志涛,等.苍术化学成分和药理的研究进展[J].中国中医药杂志,2016,41(21):3904-3911.
8、 于建玉,廖欣,丁厚伟.中药大黄药理作用研究进展及其临床应用[J].中国现代药物应用,2016,10(11):286-287. 于建玉,廖欣,丁厚伟.中药大黄药理作用研究进展及其临床应用[J].中国现代药物应用,2016,10(11):286-287.
9、 薛月萃,周英,康颖倩,等.姜黄挥发油的研究进展[J].华西药学杂志, 2016,31(2):212-215. 薛月萃,周英,康颖倩,等.姜黄挥发油的研究进展[J].华西药学杂志, 2016,31(2):212-215.
10、 MPHARM A M. Curcuma oil reduces endothelial cell-me diated inflammation in post myocardial ischemia/reperf usion in rats[J]. J Cardiovasc Pharm,2014,64(3):228- 236. MPHARM A M. Curcuma oil reduces endothelial cell-me diated inflammation in post myocardial ischemia/reperf usion in rats[J]. J Cardiovasc Pharm,2014,64(3):228- 236.
11、 ZHU C C, PENG L P, XIE Z J. External application of chinese medicine treatment of acute softtissue injury in experimental animal research progress[J]. Chin J Exp Tradit Med Form,2011,17(14):298-300. ZHU C C, PENG L P, XIE Z J. External application of chinese medicine treatment of acute softtissue injury in experimental animal research progress[J]. Chin J Exp Tradit Med Form,2011,17(14):298-300.
12、 WANG X, WANYAN P,WANG J M,et al. A Randomized controlled trial to assess the efficacy of arthroscopic debridement in combination with oral medication versus oral medication in patients with gouty knee arthritis[J].Ind J Surg,2015,77(supl 2):628-634. WANG X, WANYAN P,WANG J M,et al. A Randomized controlled trial to assess the efficacy of arthroscopic debridement in combination with oral medication versus oral medication in patients with gouty knee arthritis[J].Ind J Surg,2015,77(supl 2):628-634.
13、 KUO C F, GRAINGE M J, MALLEN C,et al. Comorbidities in patients with gout prior to and following diagnosis: case-control study[J]. Ann Rheum Dis, 2016,75(1): 210-217. KUO C F, GRAINGE M J, MALLEN C,et al. Comorbidities in patients with gout prior to and following diagnosis: case-control study[J]. Ann Rheum Dis, 2016,75(1): 210-217.
14、 REBER L L, MARICHAL T, SOKOLOVE J, et al. Contribution of mast cell-derived interleukin-1β to uric acid crystal-induced acute arthritis in mice[J]. Arthritis Rheumatol,2014,66 (10): 2881-2891. REBER L L, MARICHAL T, SOKOLOVE J, et al. Contribution of mast cell-derived interleukin-1β to uric acid crystal-induced acute arthritis in mice[J]. Arthritis Rheumatol,2014,66 (10): 2881-2891.
15、 武东,赵金霞,孙琳.痛风炎症机制的研究进展[J].中华风湿病学杂志,2014,18(2):128-130. 武东,赵金霞,孙琳.痛风炎症机制的研究进展[J].中华风湿病学杂志,2014,18(2):128-130.
16、 王玉龙,扈佐鸿,刘道碧,等.5%碳酸氢钠溶液关节镜下冲洗治疗痛风性膝关节炎[J].东南国防医药,2014,16(2):197-198,217. 王玉龙,扈佐鸿,刘道碧,等.5%碳酸氢钠溶液关节镜下冲洗治疗痛风性膝关节炎[J].东南国防医药,2014,16(2):197-198,217.
17、 WANG Y,HE M,ZHAO J X,et Al.Arthroscopic debridement for treating gouty arthritis of knee joint[J]. Chin J Clin Res,2015,28(8):1000-1002. WANG Y,HE M,ZHAO J X,et Al.Arthroscopic debridement for treating gouty arthritis of knee joint[J]. Chin J Clin Res,2015,28(8):1000-1002.
18、 WU K, CHEN Y. The curative effect on arthroscopic debridement for gouty arthritis of the knee joint Chinese[J]. J Mod Oper Surg, 2015,19(2):126-129. WU K, CHEN Y. The curative effect on arthroscopic debridement for gouty arthritis of the knee joint Chinese[J]. J Mod Oper Surg, 2015,19(2):126-129.
19、 中华医学会风湿病学分会.原发性痛风诊断和治疗指南[J].中华风湿病学杂志, 2011, 15(6): 410-413. 中华医学会风湿病学分会.原发性痛风诊断和治疗指南[J].中华风湿病学杂志, 2011, 15(6): 410-413.
20、 NEOGI T, JANSEN T L, DALBETH N, et al. 2015 gout classification criteria:an American college of rheumatology/European league against rheumatism collaborative initiative[J]. Ann Rheum Dis,2015,74(10):1789-1798. NEOGI T, JANSEN T L, DALBETH N, et al. 2015 gout classification criteria:an American college of rheumatology/European league against rheumatism collaborative initiative[J]. Ann Rheum Dis,2015,74(10):1789-1798.
21、 GARCíA-JUáREZ J D, CUELLAR-AVAROMA A, TOHEN-BIENVENU A,et al. Knee gouty monoarthritis. An arthroscopic view[J]. Acta Ortop Mex,2013,27(5):331-334. GARCíA-JUáREZ J D, CUELLAR-AVAROMA A, TOHEN-BIENVENU A,et al. Knee gouty monoarthritis. An arthroscopic view[J]. Acta Ortop Mex,2013,27(5):331-334.
22、 陈峰,孔祥峰,杨波,等.应用膝关节镜治疗痛风性膝关节炎的疗效评价[J].中华骨与关节外科杂志,2015,8(2):116-119. 陈峰,孔祥峰,杨波,等.应用膝关节镜治疗痛风性膝关节炎的疗效评价[J].中华骨与关节外科杂志,2015,8(2):116-119.
23、 MOHAMMAD S, GIATTINO S L, KEENAN R T. Current and emerging therapies for gout[J]. Curr Treat Options Rheum, 2015(1):143-155. MOHAMMAD S, GIATTINO S L, KEENAN R T. Current and emerging therapies for gout[J]. Curr Treat Options Rheum, 2015(1):143-155.
24、 WANG J Y, CHANG B C. Epidemiological characteristics and risk factors of hyperuricemia/gout [J].Int J Endocinol Metab,2016,36(2):78-81. WANG J Y, CHANG B C. Epidemiological characteristics and risk factors of hyperuricemia/gout [J].Int J Endocinol Metab,2016,36(2):78-81.
25、 CRONSTEIN B N,ROBERT T.The inflammatory process of gout and its treatment[J]. Arthritis Res Ther,2006, 8(Suppl 1):S3. CRONSTEIN B N,ROBERT T.The inflammatory process of gout and its treatment[J]. Arthritis Res Ther,2006, 8(Suppl 1):S3.
26、 GONZALEZ E B. An update on the pathology and clinical management of gouty arthritis[J]. Clin Rheumatol, 2012,31(1):13-21. GONZALEZ E B. An update on the pathology and clinical management of gouty arthritis[J]. Clin Rheumatol, 2012,31(1):13-21.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录